Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

635 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. Among authors: wray s. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results.
Naismith RT, Hendin B, Wray S, Huang D, Gaudenzi F, Dong Q, Sperling B, Mann M, Werneburg B. Naismith RT, et al. Among authors: wray s. Mult Scler J Exp Transl Clin. 2019 Jan 30;5(1):2055217318822148. doi: 10.1177/2055217318822148. eCollection 2019 Jan-Mar. Mult Scler J Exp Transl Clin. 2019. PMID: 30729026 Free PMC article.
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program.
Salvetti M, Wray S, Nelles G, Belviso N, Kumar A, Koster T, Castro-Borrero W, Vignos M; POP Investigators. Salvetti M, et al. Among authors: wray s. Mult Scler J Exp Transl Clin. 2024 May 23;10(2):20552173241238632. doi: 10.1177/20552173241238632. eCollection 2024 Apr-Jun. Mult Scler J Exp Transl Clin. 2024. PMID: 38784791 Free PMC article.
CSF neurofilament light chain profiling and quantitation in neurological diseases.
Leckey CA, Coulton JB, Giovannucci TA, He Y, Aslanyan A, Laban R, Heslegrave A, Doykov I, Ammoscato F, Chataway J, De Angelis F, Gnanapavan S, Byrne LM, Schott JM, Wild EJ, Barthelémy NR, Zetterberg H, Wray S, Bateman RJ, Mills K, Paterson RW. Leckey CA, et al. Among authors: wray s. Brain Commun. 2024 Apr 16;6(3):fcae132. doi: 10.1093/braincomms/fcae132. eCollection 2024. Brain Commun. 2024. PMID: 38707707 Free PMC article.
635 results